Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy

作者:Iwasaki H, Itoh S, Toshida K, Mita J, Ishikawa T, Iseda N, Yugawa K, Yoshiya S, Motomura T, Toshima T, Aishima S, Oda Y, Yoshizumi T · 发表于:Hepatology communications · 年份:2026 · DOI:10.1097/HC9.0000000000001014 · 被引用次数:30 · 研究领域:Liver Neoplasms、Carcinoma, Hepatocellular、Tumor Microenvironment、Bevacizumab、Immunotherapy、Antineoplastic Combined Chemotherapy Protocols、Humans、CD8-Positive T-Lymphocytes、Receptors, Immunologic、Female、Male、Single-Cell Analysis

BACKGROUND: Atezolizumab plus bevacizumab (ATZ/BEV) is a standard first-line therapy for advanced hepatocellular carcinoma (HCC); however, many patients do not achieve meaningful tumor regression. The temporal and spatial immune remodeling associated with ATZ/BEV remains poorly understood. METHODS: We performed single-cell RNA sequencing of paired hepatectomy specimens obtained before and after ATZ/BEV from one patient and of tumor center and margin samples from another patient after ATZ/BEV. Cell composition, subclusters, and cell-cell communication were analyzed. In addition, candidate molecules identified by transcriptomic analysis were further assessed using serum-based assays and immunohistochemistry. RESULTS: These single-cell analyses suggested that ATZ/BEV was associated with a shift toward an immune-active tumor microenvironment, with increased CD8+ T cells together with reduced endothelial cells. CD8+ T cells showed increased effector and exhaustion signatures, indicating coexistence of activation and dysfunction. CellChat analysis demonstrated selective activation of the TIGIT-PVR/NECTIN2 axis after treatment. Spatial analysis showed that the tumor margin was enriched for CD8+ T cells and exhibited stronger effector and exhaustion activity than the tumor center. Immunoregulatory signaling was also more prominent at the margin. Serum TIGIT levels were significantly higher after ATZ/BEV than in upfront resection cases (p=0.0325). Immunohistochemistry showed greater...